Structured evidence table for Coq10 Cognitive Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Coq10 Cognitive Performance Randomized Trial | Importantly, these biological changes manifest most meaningfully through declines in functional capacity, including reduced muscle strength, impaired metabolic regulation, diminished cognitive performance, and increased disease risk. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Cognitive Performance Randomized Trial | This article aims to synthesize evidence from human studies evaluating dietary supplements that directly or indirectly modulate the recognized hallmarks of aging, such as mitochondrial dysfunction, oxidative stress, inflammation, and proteostasis. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Cognitive Performance Randomized Trial | Rather than providing an exhaustive account of all supplements ever studied, this review focuses on representative compounds with the strongest or most emerging human evidence. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Cognitive Performance Randomized Trial | Aging is a complex, multifaceted process marked by a gradual decline in physiological. | 4 | Kurtz Jennifer A. (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits |
| Coq10 Cognitive Performance Randomized Trial | The pathogenesis of these conditions—encompassing oxidative stress, neuroinflammation, and apoptosis—is closely associated with the aging process [,,,]. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
| Coq10 Cognitive Performance Randomized Trial | Emerging evidence suggests that supplementation with selected vitamins exhibiting neuroprotective properties may effectively support mitochondrial function and neurotransmitter biosynthesis. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
| Coq10 Cognitive Performance Randomized Trial | Beyond advanced age, a key genetic determinant of AD is the presence of the apolipoprotein E ε4 allele (APOE ε4), which is strongly associated with increased deposition of beta-amyloid aggregates and the formation of characteristic senile plaques within brain tissue []. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
| Coq10 Cognitive Performance Randomized Trial | 1 2 3 4 3 5 6 Neurodegenerative diseases constitute a heterogeneous group of nervous system disorders characterized by the selective and progressive loss of neuronal populations, ultimately leading to the irreversible dysfunction of neural structures. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
Source documents